News & Articles

The serology immunoassay kit aims to help clinicians diagnose the coronavirus by analyzing the immune response against SARS-CoV-2

The new LabCollector LIMS pack aims to increase the rapidity and efficiency in COVID-19 tests management

Emergency use authorization granted for new biomaterial collection approach

The strategic partnership with Australian National Phenome Centre (ANPC) aims to support the work of their researchers

Vehicle manufacturer utilizes infrastructure to expand production to face masks and gowns for frontline medical staff

With medical equipment in short supply, the 3D printing company steps up in coronavirus crisis

Adapted breathing aid developed by UCL, UCLH and Mercedes Formula One provides vital technology to the NHS

Alliance for the scale-up of a GMP manufacturing process and production of a coronavirus (SARS-CoV-2) vaccine (ChAdOx1 nCoV-19) formed

Curiox Biosystems and STEMCELL Technologies have announced a new method to safely prepare COVID-19 blood samples for vaccine research

Canadian biotechnology company STEMCELL Technologies has provided critical support to sequence the coronavirus, accelerating vaccine development

Dolomite and Mologic are working together to scale-up the manufacturing of nanoparticles for COVID-19 diagnostic tests

Researchers from King’s College London and Imperial College London have identified a method to manipulate ventilators to supply two patients independently

Researchers from the University of Cambridge have developed a new test for coronavirus to screen frontline NHS staff

The FreeStyle Libre 14 day system can be used by frontline healthcare workers tackling the coronavirus

Watch this on-demand webinar to discover important factors in treatment approaches when confronting antimicrobial resistance

Horizon Discovery has announced a new B cell screening service to support the development of therapeutics for immune system diseases

Test runs on Bio-Rad’s QX200 and QXDx ddPCR systems and aims to provide early detection of COVID-19

Studies in China show that the QX200 ddPCR systems can detect low levels of infection in individuals

PCR Biosystems have continued to scale up their operations to ensure the ongoing availability of COVID-19 test reagents

The test results are designed to enable differential diagnosis in under 2.5 hours

Recent funding from the BARDA award helped the company accelerate development and validation

The SAMBA II machines provide a simple and accurate system for the diagnosis of COVID-19 infection